Article
Unveiling the “Template-Dependent” Inhibition on the Viral Transcription of SARS-CoV-2
30 Jul 2022
Abstract excerpt
Remdesivir is one nucleotide analogue prodrug capable to terminate RNA synthesis in SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) by two distinct mechanisms. Although the "delayed chain termination" mechanism has been extensively investigated, the "template-dependent" inhibitory mechanism remains elusive. In this study, we have demonstrated that remdesivir embedded in the template strand seldom directly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
